SLS
#1812
SELLAS Life Sciences Group, Inc. - Common Stock
13.3 4 USD
+0.01%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+0.98%
Changement Mensuel
+33.40%
Evolution sur 6 mois
+183.83%
Changement Annuel
+594.79%
Clôture Précédente
13.2 1
Open
13.3 4
Low
13.3 4
High
13.3 4
Volume
134
Financials
- Market Capitalization 2.69 B
- Employee 13
- Founded 2006
- CEO Angelos M. Stergiou
- Website www.sellaslifesciences.com
- Headquarter Delaware, United States
- FIGI BBG000VC77H7
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1764 |  ZLAB Zai Lab Limited - American Depositary Shares | 25.08 USD | -3.83% | -1.69% | +37.05% | -6.03% | 2.82 B USD | ||
| 1785 |  ATAI AtaiBeckley Inc. - Common Stock | 7.34 USD | +0.69% | -0.54% | +2.23% | +85.82% | 2.72 B USD | ||
| 1814 |  NRIX Nurix Therapeutics, Inc. - Common stock | 25.31 USD | -3.43% | -3.91% | +10.24% | +125.78% | 2.63 B USD | ||
| 1819 |  VRDN Viridian Therapeutics, Inc. - Common Stock | 22.90 USD | -0.78% | -4.78% | +21.81% | +2.00% | 2.59 B USD |